Document Detail


Comparative evaluation of nasal blood flow and airflow in the decongestant response to oxymetazoline.
MedLine Citation:
PMID:  22289724     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
BACKGROUND: Nasal blood flow (NBF) plays a crucial role in many physiological and pathological processes but its regulation and relation to other rhinological outcomes is poorly understood.
OBJECTIVES: We measured nasal airway patency, nasal blood flow, and subjective and objective measures of decongestion and assessed their reproducibility and responsiveness.
METHODS: 19 healthy adults attended twice. A dose-response curve was constructed using doubling doses of oxymetazoline of 25μg, 50μg, 100μg, and 200μg at 20 minute intervals. Peak nasal inspiratory flow (PNIF) and nasal airway resistance (NAR) were measured at baseline and after each successive dose, NBF using laser Doppler flowmetry at baseline, 50 μg and 200 μg and a decongestion visual analogue scale after the final dose.
RESULTS: After the final dose of oxymetazoline, NBF decreased by a mean (95% CI, P value) of 139.6 (108.3-170.8, P < .001) units and 99.4 (68.1-130.7, P < .001) units, PNIF increased by 48.9 (22.0-75.8, P < .001) L.min-1 and 38.9 (12.0-65.8, P = .003) L.min-1, and NAR decreased by 0.1 (0.02-0.15, P < .001) Pa/s/cm(3) and 0.09 (0.02-0.15, P = .002) Pa.s.cm-3 at the first and second visits respectively. The area under the curve of decongestion was not significantly different between visits for each variable. The standardized response means for the decongestant response were as follows: NBF, 1.41; PNIF, 1.03; and NAR, 0.97.
CONCLUSIONS: Nasal blood flow using laser Doppler flowmetry is a sensitive and reproducible outcome to decongestion with oxymetazoline, similar to nasal patency and symptoms.
CLINICAL TRIALS REGISTRATION: www.clinicaltrials.gov (NCT 00487032).
Authors:
Sriram Vaidyanathan; Peter Williamson; Brian Lipworth
Related Documents :
19403864 - Changes in cerebral blood flow, cerebral metabolites, and breathing movements in the sh...
16641214 - Surfactant protein d levels in umbilical cord blood and capillary blood of premature in...
11252134 - The role of the dorsal column pathway in visceral nociception.
22840424 - Vertical transmission of babesia microti, united states.
15003984 - Skin blood flow and plasma catecholamine concentrations during removal of a phaeochromo...
8625174 - Nourishment of hepatocellular carcinoma cells through the portal blood flow with and wi...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology     Volume:  108     ISSN:  1534-4436     ISO Abbreviation:  Ann. Allergy Asthma Immunol.     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-01-31     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9503580     Medline TA:  Ann Allergy Asthma Immunol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  77-80     Citation Subset:  IM    
Copyright Information:
Copyright © 2012. Published by Elsevier Inc.
Affiliation:
Asthma & Allergy Research Group, Centre of Cardiovascular and Lung Biology, University of Dundee, Dundee DD1 9SY, Scotland, United Kingdom.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Epigenetic Biomarkers in Skin Cancer.
Next Document:  Evaluation of the National Heart, Lung, and Blood Institute guidelines impairment domain for classif...